|
Oncology/Hematology > Lung Cancer CME/CE
Proton Tx Plus Chemo Seen Beneficial in NSCLC Median overall survival of 26.5 months in inoperable stage III disease https://www.medpagetoday.com/hematologyoncology/lungcancer/66789
0 Comments
Your comment will be posted after it is approved.
Leave a Reply. |
News and Press Releases Proton TherapyArchives
April 2019
Categories
All
|
RSS Feed